Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 50-60

  Polumuri, Swamy K ^a   Jayakar, Gift Gunaraj ^a   Shirey, Kari Ann ^a   Roberts, Zachary J ^a   Perkins, Darren J ^a   Pitha, Paula M ^b   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; ADRENALIN; BETA INTERFERON; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE RECEPTOR AGONIST; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; MDA5 AGONIST; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID INDUCIBLE PROTEIN I; RETINOIC ACID INDUCIBLE PROTEIN I AGONIST; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 3 AGONIST; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR 9 AGONIST; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; INNATE IMMUNITY; INTERFERON PRODUCTION; INTERLEUKIN 33 GENE; MACROPHAGE FUNCTION; MOUSE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEADY STATE; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERLEUKINS; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84862872341     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003554     Document Type: Article

References (68)

1. Baekkevold, E. S., M. Roussigné, T. Yamanaka, F. E. Johansen, F. L. Jahnsen, F. Amalric, P. Brandtzaeg, M. Erard, G. Haraldsen, and J. P. Girard. 2003. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163: 69-79.
2. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
3. Cayrol, C., and J. P. Girard. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
4. Oshikawa, K., K. Kuroiwa, K. Tago, H. Iwahana, K. Yanagisawa, S. Ohno, S. I. Tominaga, and Y. Sugiyama. 2001. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 164: 277-281. (Pubitemid 34001295)
5. Rössler, U., E. Thomassen, L. Hültner, S. Baier, J. Danescu, and A. K. Werenskiold. 1995. Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1-binding proteins, are differently expressed in vivo. Dev. Biol. 168: 86-97.
6. Iwahana, H., K. Yanagisawa, A. Ito-Kosaka, K. Kuroiwa, K. Tago, N. Komatsu, R. Katashima, M. Itakura, and S. Tominaga. 1999. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem. 264: 397-406. (Pubitemid 29424443)
7. Bergers, G., A. Reikerstorfer, S. Braselmann, P. Graninger, and M. Busslinger. 1994. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J. 13: 1176-1188. (Pubitemid 24074724)
8. Xu, D., W. L. Chan, B. P. Leung, F. Huang, R. Wheeler, D. Piedrafita, J. H. Robinson, and F. Y. Liew. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J. Exp. Med. 187: 787-794. (Pubitemid 28115194)
9. Meisel, C., K. Bonhagen, M. Löhning, A. J. Coyle, J. C. Gutierrez-Ramos, A. Radbruch, and T. Kamradt. 2001. Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking. J. Immunol. 166: 3143-3150. (Pubitemid 33117311)
10. Tominaga, S., K. Kuroiwa, K. Tago, H. Iwahana, K. Yanagisawa, and N. Komatsu. 1999. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem. Biophys. Res. Commun. 264: 14-18. (Pubitemid 29500455)
11. Iwahana, H., M. Hayakawa, K. Kuroiwa, K. Tago, K. Yanagisawa, S. Noji, and S. Tominaga. 2004. Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV. Biochim. Biophys. Acta 1681: 1-14. (Pubitemid 39550366)
12. Hayakawa, H., M. Hayakawa, A. Kume, and S. Tominaga. 2007. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 282: 26369-26380. (Pubitemid 47443815)
13. Chackerian, A. A., E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, and R. A. Kastelein. 2007. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179: 2551-2555.
14. Palmer, G., B. P. Lipsky, M. D. Smithgall, D. Meininger, S. Siu, D. Talabot-Ayer, C. Gabay, and D. E. Smith. 2008. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 42: 358-364.
15. Moulin, D., O. Donzé, D. Talabot-Ayer, F. Mézin, G. Palmer, and C. Gabay. 2007. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40: 216-225. (Pubitemid 350213434)
16. Ali, S., M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. U. Martin. 2007. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104: 18660-18665. (Pubitemid 350210753)
17. Allakhverdi, Z., D. E. Smith, M. R. Comeau, and G. Delespesse. 2007. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179: 2051-2054.
18. Cherry, W. B., J. Yoon, K. R. Bartemes, K. Iijima, and H. Kita. 2008. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J. Allergy Clin. Immunol. 121: 1484-1490. (Pubitemid 351787349)
19. Hudson, C. A., G. P. Christophi, R. C. Gruber, J. R. Wilmore, D. A. Lawrence, and P. T. Massa. 2008. Induction of IL-33 expression and activity in central nervous system glia. J. Leukoc. Biol. 84: 631-643.
20. Pecaric-Petkovic, T., S. A. Didichenko, S. Kaempfer, N. Spiegl, and C. A. Dahinden. 2009. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
21. Sanada, S., D. Hakuno, L. J. Higgins, E. R. Schreiter, A. N. McKenzie, and R. T. Lee. 2007. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest. 117: 1538-1549. (Pubitemid 46871338)
22. Smithgall, M. D., M. R. Comeau, B. R. Yoon, D. Kaufman, R. Armitage, and D. E. Smith. 2008. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20: 1019-1030.
23. Iikura, M., H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab. Invest. 87: 971-978. (Pubitemid 47429189)
24. Coyle, A. J., C. Lloyd, J. Tian, T. Nguyen, C. Erikkson, L. Wang, P. Ottoson, P. Persson, T. Delaney, S. Lehar, et al. 1999. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J. Exp. Med. 190: 895-902. (Pubitemid 29480818)
25. Löhning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935. (Pubitemid 28278084)
26. Smith, D. E. 2010. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin. Exp. Allergy 40: 200-208.
27. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287. (Pubitemid 46068023)
28. Roussel, L., M. Erard, C. Cayrol, and J. P. Girard. 2008. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep. 9: 1006-1012.
29. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6: 2363-2372.
30. Salkowski, C. A., K. Kopydlowski, J. Blanco, M. J. Cody, R. McNally, and S. N. Vogel. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163: 1529-1536. (Pubitemid 29352776)
31. Deonarain, R., A. Alcamí, M. Alexiou, M. J. Dallman, D. R. Gewert, and A. C. Porter. 2000. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J. Virol. 74: 3404-3409. (Pubitemid 30143766)
32. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
33. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
34. Ohno, T., K. Oboki, N. Kajiwara, E. Morii, K. Aozasa, R. A. Flavell, K. Okumura, H. Saito, and S. Nakae. 2009. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 183: 7890-7897.
35. Roberts, Z. J., N. Goutagny, P. Y. Perera, H. Kato, H. Kumar, T. Kawai, S. Akira, R. Savan, D. van Echo, K. A. Fitzgerald, et al. 2007. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J. Exp. Med. 204: 1559-1569. (Pubitemid 47049627)
36. Kato, H., O. Takeuchi, E. Mikamo-Satoh, R. Hirai, T. Kawai, K. Matsushita, A. Hiiragi, T. S. Dermody, T. Fujita, and S. Akira. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205: 1601-1610. (Pubitemid 351962024)
37. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3: 392-398. (Pubitemid 34308628)
38. Kozovska, M. E., J. Hong, Y. C. Zang, S. Li, V. M. Rivera, J. M. Killian, and J. Z. Zhang. 1999. Interferon beta induces T-helper 2 immune deviation in MS. Neurology 53: 1692-1697. (Pubitemid 29530341)
39. Whelan, J., P. Ghersa, R. Hooft van Huijsduijnen, J. Gray, G. Chandra, F. Talabot, and J. F. DeLamarter. 1991. An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 19: 2645-2653. (Pubitemid 21896900)
40. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496. (Pubitemid 36592443)
41. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737. (Pubitemid 39023305)
42. Jiang, Z., P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6: 565-570. (Pubitemid 41710726)
43. Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr, P. F. Mühlradt, and S. Akira. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164: 554-557. (Pubitemid 30043671)
44. Delghandi, M. P., M. Johannessen, and U. Moens. 2005. The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells. Cell. Signal. 17: 1343-1351. (Pubitemid 41206644)
45. Rehfuss, R. P., K. M. Walton, M. M. Loriaux, and R. H. Goodman. 1991. The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A. J. Biol. Chem. 266: 18431-18434. (Pubitemid 21908100)
46. Wiggin, G. R., A. Soloaga, J. M. Foster, V. Murray-Tait, P. Cohen, and J. S. Arthur. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22: 2871-2881. (Pubitemid 34263007)
47. Mayr, B., and M. Montminy. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2: 599-609. (Pubitemid 33674011)
48. Lee, H. J., N. Takemoto, H. Kurata, Y. Kamogawa, S. Miyatake, A. O'Garra, and N. Arai. 2000. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 192: 105-115. (Pubitemid 30470811)
49. Chen, C. H., D. H. Zhang, J. M. LaPorte, and A. Ray. 2000. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165: 5597-5605.
50. Klein-Hessling, S., T. Bopp, M. K. Jha, A. Schmidt, S. Miyatake, E. Schmitt, and E. Serfling. 2008. Cyclic AMP-induced chromatin changes support the NFATc-mediated recruitment of GATA-3 to the interleukin 5 promoter. J. Biol. Chem. 283: 31030-31037.
51. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272.
52. Meja, K. K., M. C. Catley, L. M. Cambridge, P. J. Barnes, H. Lum, R. Newton, and M. A. Giembycz. 2004. Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J. Pharmacol. Exp. Ther. 309: 833-844. (Pubitemid 38542640)
53. Johannes, F. J., J. Prestle, S. Dieterich, P. Oberhagemann, G. Link, and K. Pfizenmaier. 1995. Characterization of activators and inhibitors of protein kinase C mu. Eur. J. Biochem. 227: 303-307.
54. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
55. Der, S. D., A. Zhou, B. R. Williams, and R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 15623-15628. (Pubitemid 29018750)
56. Barnes, P. J., and I. M. Adcock. 1998. Transcription factors and asthma. Eur. Respir. J. 12: 221-234. (Pubitemid 28325681)
57. Chiappara, G., P. Chanez, A. Bruno, E. Pace, F. Pompeo, J. Bousquet, G. Bonsignore, and M. Gjomarkaj. 2007. Variable p-CREB expression depicts different asthma phenotypes. Allergy 62: 787-794. (Pubitemid 46934376)
58. Yasuda, G., S. Umemura, and W. B. Jeffries. 1997. Effect of epinephrine on cAMP accumulation in cultured rat inner medullary collecting duct cells. Am. J. Physiol. 272: F192-F197.
59. Perkins, D. J., M. C. Gray, E. L. Hewlett, and S. N. Vogel. 2007. Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1). Mol. Microbiol. 66: 1003-1015. (Pubitemid 350050425)
60. Talabot-Ayer, D., N. Calo, S. Vigne, C. Lamacchia, C. Gabay, and G. Palmer. 2012. The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J. Leukoc. Biol. 91: 119-125.
61. Allakhverdi, Z., M. R. Comeau, H. K. Jessup, B. R. Yoon, A. Brewer, S. Chartier, N. Paquette, S. F. Ziegler, M. Sarfati, and G. Delespesse. 2007. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J. Exp. Med. 204: 253-258. (Pubitemid 46294541)
62. Ying, S., B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, D. Cousins, D. Robinson, G. Zhang, J. Zhao, T. H. Lee, and C. Corrigan. 2005. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174: 8183-8190. (Pubitemid 40806330)
63. Paul, W. E., and J. Zhu. 2010. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10: 225-235.
64. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
65. Kato, A., S. Favoreto, Jr., P. C. Avila, and R. P. Schleimer. 2007. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 179: 1080-1087.
66. Lüthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
67. Miller, A. M., D. Xu, D. L. Asquith, L. Denby, Y. Li, N. Sattar, A. H. Baker, I. B. McInnes, and F. Y. Liew. 2008. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205: 339-346. (Pubitemid 351281600)
68. Humphreys, N. E., D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis. 2008. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180: 2443-2449.